Create your personal agenda –check the favourite icon
Unlocking the power of data science to change the trajectory of human health
Keynotes
Najat Khan, Chief Data Science Officer, Global Head, Strategy and Operations, Janssen Research & Development
Chair Remarks
Plenary - Genomics Live
Slave Petrovski, VP, Centre for Genomics Research, AstraZeneca
Bringing Data, Digital and Technology into Research & Development
Keynotes
Anne Heatherington, Head, Data Sciences Institute and R&D Chief Data & Technology Officer, Takeda
Large-scale data collaboration across industry and public sector: Creating a gold standard reference repository of genetic data to fuel medical research
Plenary - Genomics Live
Sebastian Wasilewski, Senior Director, Genome Informatics, AstraZeneca
Fostering entrepreneurship in pharma to drive innovation across genomics, data science and digital health
Plenary - Genomics Live
Nadeem Sarwar, Global Head, Genomic Strategies & Global Head, Digital Therapeutics (DTx) Strategies, Eisai
Panel Discussion - Illumina
Plenary - Genomics Live
Gregg Talbert, Senior Vice President, Head of Personalized Healthcare and Digital Partnering, Roche
Panel Discussion: How Data Centric approaches are transforming the Life Sciences Industry?
Keynotes
Bérénice Wulbrecht, VP Solution Delivery, ONTOFORCE
Najat Khan, Chief Data Science Officer, Global Head, Strategy and Operations, Janssen Research & Development
Faisal Khan, Corporate Vice President, Advanced Analytics, AI & RWD, Novo Nordisk
Mahesh Pancholi, Chief Information Officer, UK Biobank
Ravi Prasad, Global Head, Data and AI Stratergy and Operations, Novartis
Angeli Moller, Head of Pharma International Informatics (PIIX), Roche
Chair remarks
Image Analysis
Mishal Patel, Global Head of Imaging, AI & Data Analytics, AstraZeneca
Chair remarks
AI in Drug Development
Neel Madhukar, Chief Executive Officer, OneThree Biotech
Chair remarks
NLP
Darryl Davis, Senior Director, AstraZeneca
Chair remarks
Big Data in Oncology
Amrik Mahal, Global IT Head for Research, AstraZeneca
Chair remarks
Data Integration + FAIR
Felipe Albrecht, Senior Scientist, Discovery Informatics, Lab Automation & Data Handling, Roche
Chair remarks
Data Management, Storage and Architecture
Dan Paulson, Senior Enterprise Architect, AstraZeneca
Chair remarks
RWE
Khaled Sarsour, Vice President of Real-World Evidence (RWE) Analytics and Insights, Janssen R&D
Chair remarks
Single Cell Genomics
Caroline Gubser Keller, Global Head Chemical Biology & Therapeutics Data Science, Novartis Institutes for Biomedical Research
Chair remarks
Liquid Biopsy
Hakan Sakul, Vice President And Head Of Diagnostics, Pfizer
Chair remarks
Companion Diagnostics
Christian Ruiz, Head Diagnostic Laboratory Department, Co-Director Research Department Pathology, University Hospital Basel, Medical Genetics & Pathology
Chair remarks
Population Genomics
Thomas Hach, Executive Director, Patient Engagement Cardiovascular, Renal & Metabolism, Novartis
Exploring the role of image analysis in predictive biomarkers
Image Analysis
Radha Krishnan, Executive Director, Clinical Pathology Lead, MSD
Machine learning to identify adverse effects in scientific literature
AI in Drug Development
Sonja Wewering, Director, Digital Literature Screening Leader, Bayer
Meaning based computing beyond NLP: Integration of text-based information in digital business for faster knowledge transfer
NLP
Cedric Berger, Head of Knowledge Extraction & Integration, Roche
Using Big Data and Predictive Analytics to Determine Patients’ Profile/Risk in Oncology
Big Data in Oncology
David Dellamonica, Head, Digital and Innovation, Oncology Europe & Canada, AstraZeneca
FAIR in action – Accelerating Data Integration Using FAIR Approaches
Data Integration + FAIR
Martin Romacker, Data And Information Architect, Roche
Biological sample registration and management: Integrating data workflows
Data Management, Storage and Architecture
Benjamin Li, Head of ITRDM Biological Sample Production & Manageme, Boehringer Ingelheim USA Corporation
Building a Network of RW Data in Rare Eosinophilic Diseases (EDs)
RWE
Heide Stirnadel-Farrant, TA Evidence Strategy Lead, Immunology, AstraZeneca
Miniaturized and automated transcriptomics of clinical rare cell samples
Single Cell Genomics
Stefan Kirsch, Head Innovative Molecular Technologies & Biomarker Discovery, Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine
Liquid biopsy: From discovery to clinical application
Liquid Biopsy
Catherine Alix Panabieres, Head of Circulating Rare Cells Laboratory, C.H.R.U. Montpellier
Novel approaches to structural genomic variation
Companion Diagnostics
James Broach, Director Of The Penn State Institute For Personalized Medicine, Penn State College of Medicine
Innovation in Genomic Medicine: Insight from Africa
Population Genomics
Delali Attiogbe Attipoe, Chief Operating Officer, 54gene
Colm O'Dushlaine, Vice President, Genomics and Data Science, 54gene
Digital Pathology Biomarkers for Immuno Oncology
Image Analysis
George Lee, Digital Pathology Informatics Lead and Data Scientist, Bristol Myers Squibb
Prediction of SAE Under Reporting in Ongoing Clinical Studies
AI in Drug Development
David Heard, Global Program Director, Novartis
AI for Medical Coding
NLP
Marion Legler, Head of Decision Science & Advanced Analytics for Medical Affairs, Pharmacovigilance & Regulatory Affairs, Bayer
Big Data to Improve Cancer Patient Experience
Big Data in Oncology
Mieke Van Hemelrijck, Professor in Cancer Epidemiology, King's College London
Data integration at work: Use cases from Novartis
Data Integration + FAIR
Philippe Marc, Executive Director, Global Head Of Integrated Data Sciences, Novartis Institutes for Biomedical Research
Handling Sensitive Patient Data Across Switzerland
Data Management, Storage and Architecture
Valerie Barbie, Director Clinical Bioinformatics, SIB Swiss Institute of Bioinformatics
RWE in rare diseases, data networks and fit for purpose methods.
RWE
Daniel Rosenberg, Cross-Therapy Area Head, Global Epidemiology, Johnson & Johnson
Strategic use of single cell and tissue genomic applications in drug development
Single Cell Genomics
Tobias Bergauer, Deputy Head Genetics & Genomics, Roche
Chances and challenges for high volume liquid biopsy
Liquid Biopsy
Nikolas H Stoecklein, Professor Of Experimental Surgical Oncology General Visceral And Pediatric Surgery, University Hospital Duesseldorf
Phenome-wide association study of clonal haematopoiesis somatic mutations in 422,456 UK Biobank participants
Companion Diagnostics
Jonathan Mitchell, Genome Analyst, Astra Zeneca
Advances in genomic medicine: Enabling new capabilities for personalised care
Population Genomics
Scott Chandler, Global Head, Personalized Health Care (PHC) Safety, F. Hoffmann - La Roche
Empowering pathologists with AI authoring
Image Analysis
Volker Bruns, Group Manager Medical Image Processing, Fraunhofer IIS
Trustworthy AI for pharmaceutical research
AI in Drug Development
Tao Xu, Senior Data Scientist, Roche
Using NLP to improve patient outcomes
NLP
Elif Ozkirimli, Head of Data Science and Advanced Analytics - Pharma International Data and Analytics Chapter, Roche
Using Big Data across the NHS and healthcare providers to improve patient outcomes in cancer
Big Data in Oncology
Steven Hardy, Head of Molecular Diagnostics, National Disease Registration Service, Data Services Directorate, NHS digital
Leveraging EHR data across multiple hospitals to support integrated research platforms
Data Integration + FAIR
Nadir Ammour, Global Lead, External Engagement for Clinical Innovation Office, Sanofi
Connecting Clinical Trials to Real World Data
Data Management, Storage and Architecture
Gian Prakash, Director, Data Engineering, AbbVie
Patient held EHR: Empowering citizens to track their health and ensuring consent based access to RWD
RWE
Dominik Geller, Founder and Advisor, Hygiaso AG
Cardiac single cell analysis and novel therapies
Single Cell Genomics
Ralph Knoell, Chief Scientist, AstraZeneca
Regulatory Considerations for CDx for Medicinal Products in Oncology and Cell and Gene Therapy
Companion Diagnostics
Philipp Schatz, Global Regulatory Strategist – IVD, BAYER
Achieving greater genomic diversity in America: More diversity more learning
Population Genomics
Chris Lunt, Chief Technical Officer, National Institutes of Health, All of Us Program
Chair remarks
Image Analysis
Elton Rexhepaj, Director, Data Science, AIDA (Artificial Intelligence and Deep Analytics R&D department), Sanofi
Chair remarks
AI in Drug Development
Bonnie Kruft, Head of Research Data & Analytics, AstraZeneca
Chair remarks
Big Data in Oncology
Autri Dutta, Vice President, Lifecycle Leader - Informatics, Roche Diagnostics
Chair remarks
Data Integration + FAIR
George Papadatos, Global Head Data Strategy and Assets, Syngenta
Chair remarks
Data Management, Storage and Architecture
Andreas Steinbacher, Lead Discovery Informatics Data Management, Roche
Chair remarks
RWE
Tifani Mccann, Vice President, Chief Data and Analytics Officer, Otsuka Pharmaceutical
Chair remarks
Single Cell Genomics
Vivek Das, Senior Research Scientist, Novo Nordisk
Chair remarks
Liquid Biopsy
Sam Hanash, Director, Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, MD Anderson Cancer Center
Chair remarks
Companion Diagnostics
Carolina Haefliger, Head Translational Medicine, Debiopharm International SA
Image analysis for liver disease
Image Analysis
Benjamín Gutierrez Becker, R&D Imaging Data Analysis Expert, Roche
NLP extraction of entities from long text forms in a complex world
NLP
Fausto Artico, Global R&D Tech Head of Innovation and Data Science, GSK
Building Knowledge Graphs Across Clinical Data
Data Integration + FAIR
Ben Gardner, Product Owner for Data Mesh and Semantic Infrastructure, AstraZeneca
Cells 2.0
Data Management, Storage and Architecture
Anke Eisenmann, Principal Scientist, Hoffmann-La Roche
Establishing a platform for evidence generation: Achieving greater automation to increase speed, cost-savings and the quality of evidence
RWE
Alexander Büsser, Global RWE Analytics Lead, Idorsia
Sparsely Connected Autoencoders: a multi-purpose tool for single cell OMICs analysis
Single Cell Genomics
Raffaele Calogero, Professor, University of Torino
Exploring the challenges of early cancer detection
Liquid Biopsy
Klaus Pantel, Chairman and Professor of Medicine, Institute for Tumor Biology University of Hamburg
Companion diagnostics for homologous recombination repair in oncology
Companion Diagnostics
Timothy Schatz, Medical Director, Biomarkers and Diagnostics, Astra Zeneca
The effects of climate change on modern human populations visualised by population genomics
Population Genomics
Stephan Schuster, Professor, Nangyang Technological University
Multi-model imaging and genomic machine learning for cancer
Image Analysis
Parker Moss, Chief Commercial & Partnership Officer, Genomics England
AI for target discovery: Using interpretable AI to discover and de-risk novel targets
AI in Drug Development
Neel Madhukar, Chief Executive Officer, OneThree Biotech
Strengthening transformer-based deep neural networks for clinical and operational use
NLP
Edmon Begoli, AI Systems R&D Section Head and Distinguished Scientist, Oak Ridge National Laboratory (ORNL)
Battling data fragmentation in Oncology drug development: Advancing competitive intelligence to drive strategy
Big Data in Oncology
Subha Madhavan, Head of Data Science, Oncology R&D, AstraZeneca
Connecting the dots within the R&D data landscape: Building a solid data backbone
Data Integration + FAIR
Markus Hartmann, Head of Data Value Office, Merck
Management of internal and external data sets to improve access, efficiency and collaboration across an organisation
Data Management, Storage and Architecture
Yuliya Nigmatullina, Biomedical Data Sourcing Lead, UCB
Merging Clinical Trial & Real-World Data: A Tokenization Framework to Manage Technology, Legal, Regulatory & Privacy Concerns
RWE
Aman Thukral, Head of Digital Operations and Clinical Systems, AbbVie
Integrated Multi-Omics Reveal Polycomb Repressive Complex 2 Restricts Human Trophoblast Induction
Single Cell Genomics
Hendrik Marks, Assistant Professor and Group Leader, Radboud University Hospital
Developing novel technologies for enriching mutant sequences in liquid biopsy of cancer
Liquid Biopsy
Mike Makrigiorgos, Professor For Department Of Radiation Oncology, Dana Farber and Harvard Medical School
Theranostics in haematological malignancies
Companion Diagnostics
Stefan Habringer, Physician, Charité - Universitätsmedizin Berlin
Therapeutic gene editing: Using genomics data to target genetic diseases
Population Genomics
Grzegorz Sienski, Principal Scientist, AstraZeneca
Federated And Image Data for Improving Activity Models
Image Analysis
Hugo Ceulemans, Scientific Director, Discovery Data Sciences, Janssen Pharmaceutical NV
AI and structural biology for molecular glue degraders
AI in Drug Development
John Castle, Chief Data Science Officer, Monte Rosa Therapeutics
Automated literature reviews
NLP
Luisa Queiros, Global Access Evidence Lead, Roche
Harnessing Real World Evidence for the development of novel cancer therapies
Big Data in Oncology
Tine Lewi, Scientific Director - Patient Data for Research, Clinical Innovation, Janssen
AstraZeneca's 2 Million Genomes Initiative and the relevance of FAIR Data Principles in Pharmaceutical R & D
Data Integration + FAIR
Chuang Kee Ong, Associate Director, Lead Information Architecture, (Early Science), AstraZeneca
Re-imagine High-Quality Data Production: The Novartis journey to build a Lean Digital Core
Data Management, Storage and Architecture
Johannes Galatsanos, Head of Data, Lean Digital Core, ERP Transformation, Novartis
Share without Sharing: Privacy-Preserving, Secure Federated Analytics
RWE
Jean-Pierre Hubaux, Full Professor, Ecole Polytechnique Fédérale de Lausanne, EPFL
Functional multi-omics in precision medicine
Single Cell Genomics
Marianna Kruithof-De Julio, Head of Urology Research Laboratory and Clinical Research and Director of Organoid Core, Universitat Bern
The role of biobanking in supporting liquid biopsy research and clinical application
Liquid Biopsy
Jens K Habermann, Director General, BBMRI-ERIC
Same day tumor DNA methylation profiling: the Basel approach to diagnostic precision medicine
Companion Diagnostics
Stephan Frank, Head Neuropathology, University Hospital Basel
Latest update on the Qatar Genome Project (QGP): Moving from bench to bedside
Population Genomics
Said Ismail, Director Of Qatar Genome Programme, Qatar Foundation
Chair remarks
AI in Drug Development
Bulent Kızıltan, Head, Causal & Predictive Analytics, Novartis
Chair remarks
Big Data in Oncology
Sonia Houston Pichardo, Business Lead of MyStudyWindow, Boehringer Ingelheim
Chair remarks
Data Integration + FAIR
David Drake, Drug Discovery IT Capability Lead, AstraZeneca
Chair remarks
RWE
François-Xavier chalet, Health Economist Specialist, Idorsia
Chair remarks
Population Genomics
Ailsa Craig, Physician, Lausanne University Hospital
Digital pathology to predict genetic mutation
Image Analysis
Adrien Rousset, Head of Augmented Diagnostics & Patient Identification, Amgen
AI in drug Discovery: Recent Examples
AI in Drug Development
Rolf Jautelat, VP Strategy & Business Transformation, Bayer
Scaling natural language processing for pharmaceutical R&D and medical safety
NLP
Srikanth Ramakrishnan, Director, Pharmaceutical R&D, Intelligent Automation & Analytics, Johnson & Johnson
Information extraction for oncological purposes
Big Data in Oncology
Enrico Santus, Senior Lead Data Scientist, (Director, AI & ML), BAYER
Creation of a FAIR in-vivo data sharing platform
Data Integration + FAIR
Olivier Roche, Global Data Quality Coordinator, Biology Workflow Team Leader, Roche
BioMedIT: Switzerland’s secure IT environment for sensitive data.
Data Management, Storage and Architecture
Katrin Crameri, Head Personalised Health Informatics, SIB Swiss Institute of Bioinformatics
RWE burden of illness study in France
RWE
Darren Talbot, Global Value & Access, Senior Director, Idorsia
Fast and highly sensitive full-length single-cell RNA-sequencing using FLASH-seq
Single Cell Genomics
Simone Picelli, Platform Leader Single - Cell Genomics, Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Donor-derived cell-free DNA in transplant diagnostics
Liquid Biopsy
Michael Oellerich, Professor, University Medical Center Göttingen, George-August-University Göttingen, Germany
Donor-derived cell-free DNA in transplant diagnostics
Liquid Biopsy
Michael Oellerich, Professor, University Medical Center Göttingen, George-August-University Göttingen, Germany
Biomarkers guiding precision medicine in Psoriatic Arthritis based on genomics and proteomics analysis of clinical trials
Companion Diagnostics
Richard Siegel, Global Head, Translational Medicine, Co-Head, integrated Translational Research, Autoimmunity, Transplantation and Inflammation, Novartis
Mirroring population health models in vivo with CRISPR technology
Population Genomics
Danilo Maddalo, Group Leader - Translational Oncology, Genentech
Panel Discussion: How to harness RWE to shape clinical trial design?
RWE
Dominik Hartl, Chief Medical Officer (CMO), Quell Therapeutics
Khaled Sarsour, Vice President of Real-World Evidence (RWE) Analytics and Insights, Janssen R&D
Basker Gummadi, Head of Digital Health, Gilead Sciences
Sreeram Ramagopalan, Global Head Real-World Evidence (Market Access), Roche
Claus Andersen, Director Data Science, Galapagos
Paul Petraro, Executive Director, Global Head Real World Evidence Analytic (RWE) Center of Excellence, Boehringer Ingelheim
Melvin Olson, Global Head Integrated Evidence Strategy and Innovation, Novartis
Panel Discussion: Addressing the gap between theory and practice for AI in pharma
AI in Drug Development
Paul Agapow, Director, GSK
Victoria Gamerman, Global Head of Data Governance and Insights, Boehringer Ingelheim
Alain Bindels, Innovation & Technology Leader, Roche
Han Chang, Senior Director, Head of Late Stage Oncology, Translational Bioinformatics, Bristol-Myers Squibb
Bulent Kızıltan, Head, Causal & Predictive Analytics, Novartis
Panel Discussion
Big Data in Oncology
Sonia Houston Pichardo, Business Lead of MyStudyWindow, Boehringer Ingelheim
Martin Urban, Data Governance Manager, Boehringer-Ingelheim
Panel Discussion: Enabling access to health data while protecting privacy
Data Integration + FAIR
Nicola Orlandi, Executive Director Compliance, Head of Global Data Privacy, Bausch Health
Sidharth Jain, Head of Global Development Data Science, Janssen R&D
Tanja Stamm, Head of Section for Outcomes Research, Medical University of Vienna
Santha Ramakrishnan, Global Data Governance Lead, Sanofi
Rosie Richards, Head of European Digital Research, NHS Confederation
Sarion Bowers, Head of Policy, Wellcome Sanger Institute
Panel Discussion: Large scale genome programs – update on global genomics efforts and representation of diverse genomes
Population Genomics
Delali Attiogbe Attipoe, Chief Operating Officer, 54gene
Sàndor Szalma, Global Head, Computational Biology, Takeda
Ciara Vangjeli, Genetics Lead Director, UCB
Said Ismail, Director Of Qatar Genome Programme, Qatar Foundation
Create your personal agenda –check the favourite icon
Chair remarks
Keynotes
Alexander Krupp, Digital Lead Research, Development, Medical and Pharmacovigilance, Bayer
Chair remarks
Plenary - Genomics Live
Marc Sultan, Head Genetics & Genomics, Pharmaceutical Research and Early Development, Roche
data42: Accelerating insights from connected data to achieve greater value for patients
Keynotes
Peter Speyer, Head of Customer Success, data42, Novartis
How genomic data is helping transform lives and mainstream genomics across the NHS in England
Plenary - Genomics Live
Sue Hill, Chief Scientific Officer, NHS England
Drug Targets from large cohorts with WGS, longitudinal clinical data, and tissue single nucleus sequencing
Plenary - Genomics Live
Jeffrey Gulcher, Chief Scientific Officer, Genuity Science
Building the future of computational pathology and AI at the Mayo Clinic
Plenary - Genomics Live
Jason Hipp, Chair, Computational Pathology & AI, Mayo Clinic
Chair remarks
AI in Drug Development
Scott Oloff, SVP of Data & Analytics, pRED, Roche
Chair remarks
Big Data in Oncology
Julie Woodland, Head of Strategic Planning and Business Implementation, Astra Zeneca UK Ltd
Chair remarks
Data Integration + FAIR
Derek Marren, Principal IT Business Manager, Pre-clinical Capability, AstraZeneca
Chair remarks
Data Management, Storage and Architecture
Ralph Haffner, Head of Information Products and Data Sciences, Novartis Institutes for Biomedical Research
Chair remarks
RWE
Dorothee Bartels, Global Head RWE, UCB
Chair remarks
Companion Diagnostics
Jason Hipp, Chair, Computational Pathology & AI, Mayo Clinic
Using imaging AI to optimise clinical trials
Image Analysis
Alexander Goehler, Executive Director, Precision Medicine, Imaging and AI Lead, Novartis Institutes for Biomedical Research
Spatial Biology Biomarkers for Targeted Therapies
AI in Drug Development
Anna Pokorska-Bocci, Associate Principal Scientist, Personalised Medicine, Debiopharm
Complex terms for the medical domain.
NLP
Lonneke van der Plas, Group Leader, Idiap Research Institute
Data Catalogues
Data Integration + FAIR
Etzard Stolte, Global Head Of Knowledge Management Ptd, Roche
How RWD can help Carers in Reducing Variability in Cancer Care and Outcomes
RWE
Sanjoy Paul, Real World Evidence Leader – Oncology, AstraZeneca
Integration of multi-omics in animal models and human disease
Single Cell Genomics
Zsolt Illes, Professor, Odense University Hospital
Transformation in Cancer Care at Roche
Liquid Biopsy
Jan Hoffmann, Precision Medicine Partner, Roche
Using AI and machine learning to discover de novo biomarkers of drug response and biological drug targets
Companion Diagnostics
Graham Ball, Professor of Bioinformatics, Nottingham Trent University
Exploring pain genetics in rare diseases
Rare Diseases & NGS
Achim Kless, Pain Genetics Lead, Discovery Neuroscience Research, Neuroscience Genetics, Eli Lilly and Company
Practical application of AI for clinical imaging data
Image Analysis
Joerg Degen, Head Early Development Informatics, Roche
Implementing FAIR in early research
Data Integration + FAIR
Saritha Kuriakose, Director - Data Integration & Ontologies, novo nordisk
Prognostic biomarker Identification in Huntington’s disease with RWD machine learning modelling
RWE
Naghmeh Ghazaleh, Senior Data scientist, F. Hoffmann-La Roche
Single-cell RNA-seq in bacteria
Single Cell Genomics
Christina Homberger, Scientist NGS, Julius Maximilians Universitat Wurzburg
Towards Molecular Digital Biosensor Based Remote Clinical Trial Aided Medical Technology Technology Solutions
Liquid Biopsy
Seppo Vainio, Vice Director, GeneCellNano Academy Flagship
Logistical challenges of integrating molecular testing into daily practice of gynaecologic pathology
Companion Diagnostics
Bojana Djordjevic, Staff Pathologist, Gynaecologic Pathology Section Lead, Sunnybrook Health Sciences Centre
Genomics England: Exploring the value of sequencing all new-born children
Rare Diseases & NGS
Richard Scott, Chief Medical Officer, Genomics England
Knowledge Graph for Drug discovery
AI in Drug Development
Thierry Dorval, Head of Data Sciences & Data Management, Servier
Using computer vision to support clinical assessment and beyond
Image Analysis
John Chan, Head, ShinrAI Center for Artificial Intelligence/ Machine Learning, Takeda
Augmenting Drug Design Using Data and AI
AI in Drug Development
Prakash Rathi, Engineering Lead, Augmented Drug Design, AstraZeneca
Knowledge graphs in healthcare research
Data Management, Storage and Architecture
Alexander Jarasch, Head of Data and Knowledge Management, German Center for Diabetes Research (DZD)
Leveraging Real World Data and AI for Oncology Patient Progression Prediction
RWE
Helena Yin Koeppl, Vice President, Global Head Of Data Science And Advanced Analytics, Bayer Pharmaceuticals
Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis
Single Cell Genomics
Zhongyi Wang, postdoc, Novartis
Development and application of molecular assays for CTC’s and CtDNA
Liquid Biopsy
Evi Lianidou, Professor Of Analytical Chemistry And Clinical Chemistry, University of Athens
Metagenomic studies to detect viral and bacterial/fungal contaminants in samples to be used for human intervention
Companion Diagnostics
Dawid Walas, Global Head of Omics R&D, Merck Group
Whole genome sequencing for rare diseases and exploratory analysis for clinical trials
Rare Diseases & NGS
Sandra Smieszek, Head Of Genetics, Vanda Pharmaceuticals Inc
Chair remarks
AI in Drug Development
Daniel Joseph Price, Head of Excipent Solid Applicatin, Merck Group
Chair remarks
Big Data in Oncology
Basker Gummadi, Head of Digital Health, Gilead Sciences
Chair remarks
Data Integration + FAIR
Andrew Robertson, VP and Head of Global Regulatory Policy and Digital Innovation, Global Regulatory Affairs, Takeda
Chair remarks
RWE
Thirupathi Pattipaka, AD, Data Science, Novartis
Synthesis design system landscape for computational chemistry
Image Analysis
Jan Baumann, Principal Scientist, Research and Lab Informatics, Merck
Veit Ulshöfer, Senior Director, Global Head of Research Informatics, Merck Healthcare KGaA
Upscaling AI Powered Drug Discovery – Lessons Learnt From The Patrimony Computing Platform
AI in Drug Development
Philippe Moingeon, Head of therapeutic area immuno-inflammation. Application of AI to drug development, Servier
FAIR data integration in federated medical settings
Data Integration + FAIR
Petr Holub, Senior IT/Data Protection Manager, BBMRI-ERIC
Qualifications based access data: Innovative model for data governance
Data Management, Storage and Architecture
David Hurry, Head, Data Services and Content Delivery, Takeda Research & Development Center, Inc.
Bioinformatics and Target Discovery in times of high-throughput multi-modal technologies.
Single Cell Genomics
Vivek Das, Senior Research Scientist, Novo Nordisk
Genetics in Drug Development
Companion Diagnostics
Dipender Gill, Advanced Research Fellow, Imperial College London
AstraZeneca’s Genomics initiative – insights into heart failure
Rare Diseases & NGS
Dirk Paul, CVRM Genomics Therapy Area, AstraZeneca
DNA methylome sequencing – insight into epigenetics of non-small-cell lung cancer
Rare Diseases & NGS
Miljana Tanic, Senior Research Associate – Principal Investigator, Institute for Oncology and Radiology of Serbia
Decoding neurodegenerative disorders combining AI and high content imaging
Image Analysis
Raphaëlle Luisier, Group Leader, Idiap Research Institute
Computational chemistry and data science for formulation development
AI in Drug Development
David Luedeker, Principal Scientist, Merck Healthcare KGaA
Drug discovery in the bacterial space with AI supported semantic technologies
Data Integration + FAIR
Sebastian Scharf, Senior Data Scientist, Roche
FAIR data hub for analytical chemistry data
Data Management, Storage and Architecture
Arndt Finkelmann, RnD IT Operations Lead, Syngenta Crop Protection AG
Use of Real world data for Safety
RWE
Jost Leemhuis, Head Of Safety Science, Roche
Immuno Precision Medicine for Cardiovascular Disease Patients
Single Cell Genomics
Stefan Bekiranov, Associate Professor, University of Virginia School of Medicine
The wide world of liquid biopsy platforms for cancer early detection
Liquid Biopsy
Sam Hanash, Director, Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, MD Anderson Cancer Center
Recommending the International Use of a Low-Cost, Sensitive, HIV-1 Total HIV-1 Nucleic Acid Quantitative Assay with Broad Subtype Specificity
Companion Diagnostics
Catherine Kibirige, Research Associate, Imperiai College London
Benefit of Basket Trials with rare disease patients of shared molecular etiology
Rare Diseases & NGS
Christina Waters, Chief Executive Officer, RARE Science
Use of machine learning in an image analysis pipeline to assess Covid Antibody Status in home tests.
Image Analysis
Anil Bharath, Founder, Imperial College London
Not Just Deep Fakes: Applications of Visual Generative AI Models in Pharma Manufacturing
AI in Drug Development
Guglielmo Iozzia, Associate Director - Business Tech Analysis, Machine Learning and AI, MSD
FAIRness evaluation: Commercial application and opportunities
Data Integration + FAIR
Michel Dumontier, Distinguished Professor Of Data Sciences And Co-Founder Of The Fair Data Principles, Universiteit Maastricht
Development of tools and ontologies for semantically annotated scientific data for AI and machine learning applications
Data Management, Storage and Architecture
Mark Doerr, Senior Scientist, University Greifswald
Unblocking the value of data through partnerships
RWE
Meni Styliadou, VP Distinguished Fellow, Data Science Institute, Takeda Europe R&D
From single cell to precision medicine
Single Cell Genomics
Panagiotis Chouvardas, PostDoc Researcher Computational Biologist, University of Bern
Harnessing the power of omics for precision diagnostics
Companion Diagnostics
Gina Fioretti, Executive Director of Genomics, Recuro Health
Using biobank level exome sequencing to study rare diseases
Rare Diseases & NGS
Luke Ward, Associate Director, Human Genetics, Alnylam Pharmaceuticals
Chair remarks
Data Integration + FAIR
Marco Giannitrapani, VP of Global Data & Analytics - Go To Market, Roche
Chair remarks
RWE
Martina von Meyenn, Global Medical Chapter Lead, Real World Evidence, Roche
Real life AI: Opportunities and pitfalls in healthcare
AI in Drug Development
Faisal Khan, Corporate Vice President, Advanced Analytics, AI & RWD, Novo Nordisk
Leveraging AI and Big data for new target discovery for Oncology
Big Data in Oncology
Miika Ahdesmaki, Director, Early Computational Oncology, AstraZeneca
Dimitris Polychronopoulos, Associate Director, AstraZeneca
How the lines between health systems and pharma should be redrawn to allow patient data flow: The platformisation of clinical data
Data Integration + FAIR
Alex Sherman, Director, Center for Innovation and BioInformatics Neurological Clinical Research Institute, Massachusetts General Hospital
NIBR’s Journey to Digitalize Biologics Discovery – Value Chain
Data Management, Storage and Architecture
Bjorn Schuller, Professor of AI & Chair of Embedded Intelligence for Health Care and Wellbeing, Imperial College London
Drazen Nadoveza, Senior Principal Software Engineer, Technical Lead – NIBR Informatics, ENG, Novartis
Developing clinically relevant predictive analytic tools from patient, clinical and lab data
RWE
William Paiva, Managing Partner, Oklahoma Life Science Fund
Modelling single cell dynamics for immunology
Single Cell Genomics
Ziv Bar-Joseph, Head, R&D Data and Computational Sciences, Sanofi
Sample handling strategies for liquid biopsy
Liquid Biopsy
Thomas Valentin, Group Leader - Sample Handling & Sensing, CSEM SA
Presentation
Companion Diagnostics
Gurvinder Kenth, Senior Manager, Global Diagnostics Excellence, Astra Zeneca
Genetic and pharmacological causes of germline hypermutation
Rare Diseases & NGS
Matthew Neville, PhD Candidate, Wellcome Sanger Institute
FAIR in the Swiss personalised health network (SPHN)
Data Integration + FAIR
Sabine Österle, Team Lead Data Interoperability, SIB Swiss Institute of Bioinformatics
Panel Discussion: Alliance for Artificial Intelligence in Healthcare: A pre-competitive approach
AI in Drug Development
Angeli Moller, Head of Pharma International Informatics (PIIX), Roche
Panel Discussion: The Variations and Inequality in Cancer Care
Big Data in Oncology
Sanjoy Paul, Real World Evidence Leader – Oncology, AstraZeneca
Panel Discussion: Strengthening Data, Digital and AI Approaches in Medical Oncology
RWE
Fareed. Mirza, Global Head of Data Alliances, AstraZeneca
Joel Greshock, Vice President of Data Sciences, Oncology, Janssen
Panel Discussion: Community standards for integrating genomics with other data types for rare disease patients
Rare Diseases & NGS
Ramona Walls, Associate Director of Data Science, Critical Path Institute
Create your personal agenda –check the favourite icon
Chair remarks
Keynotes
Shubha Chaudhari, Head of Clinical Technology Solutions, GSK
The future of RWD: Harnessing RWD to accelerate drug development
Keynotes
Christopher Boone, VP, Global Head, Health Economics & Outcomes Research, AbbVie
Chair remarks
Plenary - Genomics Live
Paul Nioi, Vice President, Discovery and Translational Research, Alnylam Pharmaceuticals
A Computer Science Looks at Discovery Science
Keynotes
Hal Stern, VP & CIO, Pharmaceutical R&D, Janssen
Benchmarking ctDNA
Plenary - Genomics Live
Maria Karasarides, Vice-President, Head Early Assets & Biomarkers, Bristol-Myers Squibb
What does digital transformation mean for Big Pharma?
Keynotes
Thomas Senderovitz, Senior Vice President, Data Science, Novo Nordisk A/S
Chair remarks
AI in Drug Development
Markus Hinder, Head Patient Safety, Novartis Pharma AG
Chair remarks
Data Management, Storage and Architecture
Susan Gregurick, Associate Director for Data Science, National Institutes of Health
Chair remarks
RWE
Teddy Sun, Evidence Generation Lead, Takeda
Challenges and opportunities of using AI for drug development
AI in Drug Development
Nuray Yurt, Global Head, Artificial Intelligence (AI) Solutions, Global Data & Digital, Novartis
Beyond Data Strategy Shifting Gears from Data Planning to Data Doing
Data Integration + FAIR
Magdalena Wienken, Associate Director & Team Lead TM Data Ops & Governance, AstraZeneca
NIH Strategic Plan for Data Science: Challenges and Opportunities
Data Management, Storage and Architecture
Susan Gregurick, Associate Director for Data Science, National Institutes of Health
How do you approach your real world evidence data capturing: Big Data vs Targeted Data
RWE
Vidya Breeveld, Founder, Transmineo
Spatial transcriptomics in GI disorders
Single Cell Genomics
Sarah Harris, Head, GI and Neurology Disease Teams, Translational Medicine, Bristol Myers Squibb
The use of liquid biopsies as a monitoring tool for solid tumour indications
Liquid Biopsy
Jan Christoph Brase, Global Biomarker Diagnostic Leader, Novartis
Accelerating precision medicine trials with digital and at-home genomic testing
Rare Diseases & NGS
Patrick Short, Chief Executive Officer, Sano Genetics
Target identification and validation methods, leveraging large-scale cohort data and machine learning
AI in Drug Development
Dimitrios Vitsios, Research Associate, AstraZeneca
Faster and Better: automating data between Electronic Health Records and Electronic Data Capture systems at hospitals
Data Management, Storage and Architecture
Mats Sundgren, Health Data Science Director, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca
Challenges of generating evidence for rare diseases in Europe
RWE
Giovanna Barcelos, HEOR RWE Senior Manager, Europe & GCC, Global Blood Therapeutics
With technology to biology: How single cell methods revolutionize the functional genomics field
Single Cell Genomics
Daniel Schraivogel, Research Staff Scientist, EMBL
Why biobanking is the most important tool for rare disease research
Rare Diseases & NGS
Karine Sargsyan, Managing Director of International Biobanking, Medizinische Universitat Graz
Testing for rare genetic diseases of obesity
Rare Diseases & NGS
Patrick Kleyn, Senior Vice President, Translational Research & Development, Rhythm Pharmaceuticals
Machine learning on GWAS and Biobank data for novel therapeutic translation
AI in Drug Development
Zhihao Ding, Head of Human Genetics, Boehringer-Ingelheim
Data strategy, FAIRification and curation at Roche
Data Integration + FAIR
Silvia Jimenez, Senior Scientist, Roche
GA4GH: enabling responsible and effective data use
Data Management, Storage and Architecture
Fabio Liberante, Postdoctoral Fellow, Wellcome Trust Sanger Institute
Maili Raven-Adams, Policy Analyst, Global Alliance for Genomics & Health
Liquid biopsy in kidney transplant care: A clinician’s perspective
Liquid Biopsy
Bilgin Osmanodja, Physician, Charite
NGS and personalised medicine in solid tumours
Rare Diseases & NGS
Michael Uhlin, Professor Clinical Immunology, Karolinska University Hospital
Chair remarks
AI in Drug Development
Sotirios Perdikeas, Senior Principal Scientist and People Coach, Predictive Modelling and Data Analytics, R&D, Roche
Chair remarks
RWE
Erwan Muros-Le Rouzic, Senior Principal RWD Scientist/Epidemiologist, Roche
Application Of Clinical Genomic Medicine Data to Drug Discovery and Development
AI in Drug Development
Pierre Farmer, Head, in silico Lead Discovery Basel, novartis
Health research data ecosystem
Data Integration + FAIR
Harpreet Singh, Scientist, Indian Council of Medical Research
Implementation of NGS technology for whole genome sequencing in microbiology
Single Cell Genomics
Dunstan Rajendram, Senior Scientist, UK Health Security Agency
The perfect match: cellular biomarkers demonstrating how APDS has met its therapy
Rare Diseases & NGS
Ulrike Sommer, Senior Principal Scientist, Novartis Institutes for Biomedical Research
Adverse events in the Digital age
AI in Drug Development
Robert Di Giovanni, Global patient safety lead, Novartis Pharma AG
Healthcare Data engineering using graphs
Data Integration + FAIR
Lukasz Kaczmarek, Data Architect, Roche
Andrew Nguyen, Data Architecture & Informatics Capability Lead, Roche Real World Data Hub, Genetech
Using single cell genomics to identify targets for metastasis and therapy resistance in breast cancer
Single Cell Genomics
Vijay Tiwari, Professor and Group Head, Genomics and Data Science in Precision Medicine Laboratory, Wellcome-Wolfson Institute For Experimental Medicine, Queen's University Belfast
Safety of gene therapy for rare diseases
Rare Diseases & NGS
Saumyaa Saumyaa, Senior Research Scientist, Astra Zeneca
Demonstrating how ‘Big Pharma’ can successfully transform it’s R&D activities using data & advanced analytics/AI from drug discovery through to regulatory submissions
AI in Drug Development
Eric Genevois-Marlin, Head of RD Data and Data Sciences (DDS), Sanofi
Informatics ecosystems supporting FAIR data integration in clinical studies
Data Integration + FAIR
Holmfridur Thorsteinsdottir, Head Clinical & Biomarker Informatics, Roche
Proteomics analysis in SLE and Sjogren 's syndrome
Rare Diseases & NGS
Andrea Grioni, Senior Data Scientist, Novartis Institutes for Biomedical Research
last published: 30/Jun/22 10:56 GMT
Password must meet the following requirements:
- At least one letter
- At least one capital letter
- At least one number
- Be at least 6 characters